perfosfamide has been researched along with Carcinoma, Lewis Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckett, MA; Gupta, VK; Koons, A; Kufe, DW; Lee, JY; Manan, A; Mauceri, HJ; Montag, AG; Park, JO; Schumm, LP; Seetharam, S; Weichselbaum, RR | 1 |
Dupuis, NP; Emi, Y; Goff, DA; Robinson, MF; Teicher, BA | 1 |
2 other study(ies) available for perfosfamide and Carcinoma, Lewis Lung
Article | Year |
---|---|
Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Endothelium, Vascular; Humans; Linear Models; Lung Neoplasms; Mice; Mice, Inbred C57BL; Morphogenesis; Neoplasm Metastasis; Neovascularization, Physiologic; Peptide Fragments; Plasminogen; Protein Synthesis Inhibitors; Single-Blind Method; Tumor Cells, Cultured | 2002 |
Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carmustine; Cell Hypoxia; Cell Survival; Cisplatin; Cyclohexanes; Cyclophosphamide; DNA, Neoplasm; Drug Combinations; Male; Melphalan; Mice; Mice, Inbred C57BL; Minocycline; O-(Chloroacetylcarbamoyl)fumagillol; Platinum; Sesquiterpenes; Tumor Cells, Cultured | 1995 |